What is xeroderma pigmentosum?

xeroderma pigmentosum is a very rare genetic state characterized by extreme photoccitation in the skin. The existence of this condition varies, and some of the populations seem more vulnerable than others. The condition was identified as a recessive property, which means that someone must inherit two copies of a defective gene in order to have xeroderma pigmentosum. Men and women can be carriers and men and women are at the same risk of condition. In all cases, enzymes that are responsible for repairing skin cells damaged by ultraviolet radiation, somehow defective. This means that when skin cells are damaged by the sun, the body cannot repair them. As a result, patients develop a number of dermatological symptoms. Over time, the skin can undergo varieties change, discoloration, growth and changes in texture. The skin can be thickened or thin, darkened or has become lighter and developed lesions. The more the patient is exposed to the sun, the worse the skin changes are.

The biggest complication of Xeroderma pigmentosum is cancer. Patients with this condition are a very high risk of developing skin cancer and skin cancer are the main cause of death for people with xeroderma pigmentosum. For this reason, patients are usually carefully monitored by a dermatologist throughout their lifetime, so signs of abnormal cell growth can be quickly identified and solved.

This condition cannot be cured, but can be managed. Patients with Xeroderma pigmentosum are usually recommended to stay outside the sun and wear protection when they are in an environment with ultraviolet radiation. Many organizations will support night events, night camps and other special events that are adapted to people with this condition, allowing patients to meet each other and share experience with people who understand their condition.

To have a rare genetic state may feel the alienation for patients, especially when it causes physical changes that can attract attention, which will be SOCial situation unpleasant. Patients with Xeroderma pigmentosum may benefit from the combination of groups that advocate patients, provide people with new information about treatment and organize social actions to allow patients a network. Parents of children with this situation should not be accused because there is nothing to do to prevent a genetic lottery that causes a child to inherit two defective genes, although parents may want to look for genetic testing and advice to learn more.